Articles Mentioning Pharmaceuticals Stocks

Results 1 - 10 of 979 : 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for Pharmaceuticals

Investing | August 17, 2016

Better Buy: AbbVie Inc. vs. Eli Lilly & Co.

Let's look at the challenges and opportunities facing these Big Pharma stocks to see which is most attractive now.

Investing | August 12, 2016

Prices for These 4 Top-Selling Prescription Drugs Have More Than Doubled Since 2010

Inherent advantages in the healthcare system for drugmakers are fueling soaring drug prices.

Investing | August 10, 2016

After Opdivo's Failure, Is Merck a Better Buy Than Bristol-Myers?

A high-profile failure in lung cancer patients punished Bristol-Myers Squibb's invetors and rewarded Merck & Co.'s investors.

Investing | July 30, 2016

How I Got a Safe 9% Dividend Yield -- and You Can, Too!

If you buy and hold stocks with these three traits, you can catch these fat yields, too!

Investing | July 25, 2016

5 Incredibly Cheap Big Pharma Stocks

Looking for inexpensive stocks to ride an aging demographic trend? These five Big Pharma stocks are trading at steep discounts.

Investing | July 23, 2016

In Case You Missed It, 5 New Lung Cancer Drugs Have Been Approved Since October

Don't blink, otherwise you could miss another innovative cancer drug hitting pharmacy shelves.

Investing | July 18, 2016

Is This Gilead Sciences' Most Underappreciated Drug Candidate?

This experimental anti-cancer drug has jaw-dropping commercial potential.

Investing | July 14, 2016

3 Dividend Aristocrats to Avoid

Investment decisiones should be based on future potential, not past dividend growth.

Investing | July 05, 2016

How Gilead's New Hepatitis C Virus Combination Stacks Up to the Competition

Gilead's pan-genotypic hepatitis C virus combo, Epclusa, could significantly boost the company's sales by filling some important niches.

Investing | July 03, 2016

The Big Loser After Gilead's Latest Approval May Not Be Who You Think (Hint: It's not AbbVie, Inc.)

The approval of Epclusa could shake up how doctors treat hepatitis C patients with tough-to-treat genotypes of the disease.

Results 1 - 10 of 979 : 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for Pharmaceuticals